Click for best price
Dendritic Cell Cancer Vaccine Market Size, Share 2022
Dendritic cells (DCs) refer to rare kind of leukocytes. They have prompted their recent application to therapeutic cancer vaccinations as they are uniquely effective in their ability to present antigens to T cells.
This report contains market size and forecasts of Dendritic Cell Cancer Vaccine in global, including the following market information:
Global Dendritic Cell Cancer Vaccine Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Dendritic Cell Cancer Vaccine Market Sales, 2017-2022, 2023-2028, (K Doses)
Global top five Dendritic Cell Cancer Vaccine companies in 2021 (%)
The global Dendritic Cell Cancer Vaccine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
CreaVax Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Dendritic Cell Cancer Vaccine include Activarti, Argos Therapeutics, SOTIO (Acquired by PPF Group), Bellicum Pharmaceuticals, JW CreaGene, DanDrit, DCPrime, Elios Therapeutics and ImmunoCellular Therapeutics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Dendritic Cell Cancer Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Dendritic Cell Cancer Vaccine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Doses)
Global Dendritic Cell Cancer Vaccine Market Segment Percentages, by Type, 2021 (%)
CreaVax
Sipuleucel-T (Provenge)
Others
Global Dendritic Cell Cancer Vaccine Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Doses)
Global Dendritic Cell Cancer Vaccine Market Segment Percentages, by Application, 2021 (%)
Pediatrics
Adults
Global Dendritic Cell Cancer Vaccine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Doses)
Global Dendritic Cell Cancer Vaccine Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Dendritic Cell Cancer Vaccine revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Dendritic Cell Cancer Vaccine revenues share in global market, 2021 (%)
Key companies Dendritic Cell Cancer Vaccine sales in global market, 2017-2022 (Estimated), (K Doses)
Key companies Dendritic Cell Cancer Vaccine sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Activarti
Argos Therapeutics
SOTIO (Acquired by PPF Group)
Bellicum Pharmaceuticals
JW CreaGene
DanDrit
DCPrime
Elios Therapeutics
ImmunoCellular Therapeutics
Kiromic
Medigene
Merck
Northwest Biotherapeutics
Immutep Limited
Dendreon Corporation
Oncobiomed
| Report Attributes |
Report Details |
| Report Title |
Dendritic Cell Cancer Vaccine Market, Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
114 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Dendritic Cell Cancer Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Dendritic Cell Cancer Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Dendritic Cell Cancer Vaccine Overall Market Size
2.1 Global Dendritic Cell Cancer Vaccine Market Size: 2021 VS 2028
2.2 Global Dendritic Cell Cancer Vaccine Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Dendritic Cell Cancer Vaccine Sales: 2017-2028
3 Company Landscape
3.1 Top Dendritic Cell Cancer Vaccine Players in Global Market
3.2 Top Global Dendritic Cell Cancer Vaccine Companies Ranked by Revenue
3.3 Global Dendritic Cell Cancer Vaccine Revenue by Companies
3.4 Global Dendritic Cell Cancer Vaccine Sales by Companies
3.5 Global Dendritic Cell Cancer Vaccine Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Dendritic Cell Cancer Vaccine Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Dendritic Cell Cancer Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Dendritic Cell Cancer Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Dendritic Cell Cancer Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Dendritic Cell Cancer Vaccine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Dendritic Cell Cancer Vaccine Market Size Markets, 2021 & 2028
4.1.2 CreaVax
4.1.3 Sipuleucel-T (Provenge)
4.1.4 Others
4.2 By Type - Global Dendritic Cell Cancer Vaccine Revenue & Forecasts
4.2.1 By Type - Global Dendritic Cell Cancer Vaccine Revenue, 2017-2022
4.2.2 By Type - Global Dendritic Cell Cancer Vaccine Revenue, 2023-2028
4.2.3 By Type - Global Dendritic Cell Cancer Vaccine Revenue Market Share, 2017-2028
4.3 By Type - Global Dendritic Cell Cancer Vaccine Sales & Forecasts
4.3.1 By Type - Global Dendritic Cell Cancer Vaccine Sales, 2017-2022
4.3.2 By Type - Global Dendritic Cell Cancer Vaccine Sales, 2023-2028
4.3.3 By Type - Global Dendritic Cell Cancer Vaccine Sales Market Share, 2017-2028
4.4 By Type - Global Dendritic Cell Cancer Vaccine Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Dendritic Cell Cancer Vaccine Market Size, 2021 & 2028
5.1.2 Pediatrics
5.1.3 Adults
5.2 By Application - Global Dendritic Cell Cancer Vaccine Revenue & Forecasts
5.2.1 By Application - Global Dendritic Cell Cancer Vaccine Revenue, 2017-2022
5.2.2 By Application - Global Dendritic Cell Cancer Vaccine Revenue, 2023-2028
5.2.3 By Application - Global Dendritic Cell Cancer Vaccine Revenue Market Share, 2017-2028
5.3 By Application - Global Dendritic Cell Cancer Vaccine Sales & Forecasts
5.3.1 By Application - Global Dendritic Cell Cancer Vaccine Sales, 2017-2022
5.3.2 By Application - Global Dendritic Cell Cancer Vaccine Sales, 2023-2028
5.3.3 By Application - Global Dendritic Cell Cancer Vaccine Sales Market Share, 2017-2028
5.4 By Application - Global Dendritic Cell Cancer Vaccine Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Dendritic Cell Cancer Vaccine Market Size, 2021 & 2028
6.2 By Region - Global Dendritic Cell Cancer Vaccine Revenue & Forecasts
6.2.1 By Region - Global Dendritic Cell Cancer Vaccine Revenue, 2017-2022
6.2.2 By Region - Global Dendritic Cell Cancer Vaccine Revenue, 2023-2028
6.2.3 By Region - Global Dendritic Cell Cancer Vaccine Revenue Market Share, 2017-2028
6.3 By Region - Global Dendritic Cell Cancer Vaccine Sales & Forecasts
6.3.1 By Region - Global Dendritic Cell Cancer Vaccine Sales, 2017-2022
6.3.2 By Region - Global Dendritic Cell Cancer Vaccine Sales, 2023-2028
6.3.3 By Region - Global Dendritic Cell Cancer Vaccine Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Dendritic Cell Cancer Vaccine Revenue, 2017-2028
6.4.2 By Country - North America Dendritic Cell Cancer Vaccine Sales, 2017-2028
6.4.3 US Dendritic Cell Cancer Vaccine Market Size, 2017-2028
6.4.4 Canada Dendritic Cell Cancer Vaccine Market Size, 2017-2028
6.4.5 Mexico Dendritic Cell Cancer Vaccine Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Dendritic Cell Cancer Vaccine Revenue, 2017-2028
6.5.2 By Country - Europe Dendritic Cell Cancer Vaccine Sales, 2017-2028
6.5.3 Germany Dendritic Cell Cancer Vaccine Market Size, 2017-2028
6.5.4 France Dendritic Cell Cancer Vaccine Market Size, 2017-2028
6.5.5 U.K. Dendritic Cell Cancer Vaccine Market Size, 2017-2028
6.5.6 Italy Dendritic Cell Cancer Vaccine Market Size, 2017-2028
6.5.7 Russia Dendritic Cell Cancer Vaccine Market Size, 2017-2028
6.5.8 Nordic Countries Dendritic Cell Cancer Vaccine Market Size, 2017-2028
6.5.9 Benelux Dendritic Cell Cancer Vaccine Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Dendritic Cell Cancer Vaccine Revenue, 2017-2028
6.6.2 By Region - Asia Dendritic Cell Cancer Vaccine Sales, 2017-2028
6.6.3 China Dendritic Cell Cancer Vaccine Market Size, 2017-2028
6.6.4 Japan Dendritic Cell Cancer Vaccine Market Size, 2017-2028
6.6.5 South Korea Dendritic Cell Cancer Vaccine Market Size, 2017-2028
6.6.6 Southeast Asia Dendritic Cell Cancer Vaccine Market Size, 2017-2028
6.6.7 India Dendritic Cell Cancer Vaccine Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Dendritic Cell Cancer Vaccine Revenue, 2017-2028
6.7.2 By Country - South America Dendritic Cell Cancer Vaccine Sales, 2017-2028
6.7.3 Brazil Dendritic Cell Cancer Vaccine Market Size, 2017-2028
6.7.4 Argentina Dendritic Cell Cancer Vaccine Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Dendritic Cell Cancer Vaccine Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Dendritic Cell Cancer Vaccine Sales, 2017-2028
6.8.3 Turkey Dendritic Cell Cancer Vaccine Market Size, 2017-2028
6.8.4 Israel Dendritic Cell Cancer Vaccine Market Size, 2017-2028
6.8.5 Saudi Arabia Dendritic Cell Cancer Vaccine Market Size, 2017-2028
6.8.6 UAE Dendritic Cell Cancer Vaccine Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Activarti
7.1.1 Activarti Corporate Summary
7.1.2 Activarti Business Overview
7.1.3 Activarti Dendritic Cell Cancer Vaccine Major Product Offerings
7.1.4 Activarti Dendritic Cell Cancer Vaccine Sales and Revenue in Global (2017-2022)
7.1.5 Activarti Key News
7.2 Argos Therapeutics
7.2.1 Argos Therapeutics Corporate Summary
7.2.2 Argos Therapeutics Business Overview
7.2.3 Argos Therapeutics Dendritic Cell Cancer Vaccine Major Product Offerings
7.2.4 Argos Therapeutics Dendritic Cell Cancer Vaccine Sales and Revenue in Global (2017-2022)
7.2.5 Argos Therapeutics Key News
7.3 SOTIO (Acquired by PPF Group)
7.3.1 SOTIO (Acquired by PPF Group) Corporate Summary
7.3.2 SOTIO (Acquired by PPF Group) Business Overview
7.3.3 SOTIO (Acquired by PPF Group) Dendritic Cell Cancer Vaccine Major Product Offerings
7.3.4 SOTIO (Acquired by PPF Group) Dendritic Cell Cancer Vaccine Sales and Revenue in Global (2017-2022)
7.3.5 SOTIO (Acquired by PPF Group) Key News
7.4 Bellicum Pharmaceuticals
7.4.1 Bellicum Pharmaceuticals Corporate Summary
7.4.2 Bellicum Pharmaceuticals Business Overview
7.4.3 Bellicum Pharmaceuticals Dendritic Cell Cancer Vaccine Major Product Offerings
7.4.4 Bellicum Pharmaceuticals Dendritic Cell Cancer Vaccine Sales and Revenue in Global (2017-2022)
7.4.5 Bellicum Pharmaceuticals Key News
7.5 JW CreaGene
7.5.1 JW CreaGene Corporate Summary
7.5.2 JW CreaGene Business Overview
7.5.3 JW CreaGene Dendritic Cell Cancer Vaccine Major Product Offerings
7.5.4 JW CreaGene Dendritic Cell Cancer Vaccine Sales and Revenue in Global (2017-2022)
7.5.5 JW CreaGene Key News
7.6 DanDrit
7.6.1 DanDrit Corporate Summary
7.6.2 DanDrit Business Overview
7.6.3 DanDrit Dendritic Cell Cancer Vaccine Major Product Offerings
7.6.4 DanDrit Dendritic Cell Cancer Vaccine Sales and Revenue in Global (2017-2022)
7.6.5 DanDrit Key News
7.7 DCPrime
7.7.1 DCPrime Corporate Summary
7.7.2 DCPrime Business Overview
7.7.3 DCPrime Dendritic Cell Cancer Vaccine Major Product Offerings
7.7.4 DCPrime Dendritic Cell Cancer Vaccine Sales and Revenue in Global (2017-2022)
7.7.5 DCPrime Key News
7.8 Elios Therapeutics
7.8.1 Elios Therapeutics Corporate Summary
7.8.2 Elios Therapeutics Business Overview
7.8.3 Elios Therapeutics Dendritic Cell Cancer Vaccine Major Product Offerings
7.8.4 Elios Therapeutics Dendritic Cell Cancer Vaccine Sales and Revenue in Global (2017-2022)
7.8.5 Elios Therapeutics Key News
7.9 ImmunoCellular Therapeutics
7.9.1 ImmunoCellular Therapeutics Corporate Summary
7.9.2 ImmunoCellular Therapeutics Business Overview
7.9.3 ImmunoCellular Therapeutics Dendritic Cell Cancer Vaccine Major Product Offerings
7.9.4 ImmunoCellular Therapeutics Dendritic Cell Cancer Vaccine Sales and Revenue in Global (2017-2022)
7.9.5 ImmunoCellular Therapeutics Key News
7.10 Kiromic
7.10.1 Kiromic Corporate Summary
7.10.2 Kiromic Business Overview
7.10.3 Kiromic Dendritic Cell Cancer Vaccine Major Product Offerings
7.10.4 Kiromic Dendritic Cell Cancer Vaccine Sales and Revenue in Global (2017-2022)
7.10.5 Kiromic Key News
7.11 Medigene
7.11.1 Medigene Corporate Summary
7.11.2 Medigene Dendritic Cell Cancer Vaccine Business Overview
7.11.3 Medigene Dendritic Cell Cancer Vaccine Major Product Offerings
7.11.4 Medigene Dendritic Cell Cancer Vaccine Sales and Revenue in Global (2017-2022)
7.11.5 Medigene Key News
7.12 Merck
7.12.1 Merck Corporate Summary
7.12.2 Merck Dendritic Cell Cancer Vaccine Business Overview
7.12.3 Merck Dendritic Cell Cancer Vaccine Major Product Offerings
7.12.4 Merck Dendritic Cell Cancer Vaccine Sales and Revenue in Global (2017-2022)
7.12.5 Merck Key News
7.13 Northwest Biotherapeutics
7.13.1 Northwest Biotherapeutics Corporate Summary
7.13.2 Northwest Biotherapeutics Dendritic Cell Cancer Vaccine Business Overview
7.13.3 Northwest Biotherapeutics Dendritic Cell Cancer Vaccine Major Product Offerings
7.13.4 Northwest Biotherapeutics Dendritic Cell Cancer Vaccine Sales and Revenue in Global (2017-2022)
7.13.5 Northwest Biotherapeutics Key News
7.14 Immutep Limited
7.14.1 Immutep Limited Corporate Summary
7.14.2 Immutep Limited Business Overview
7.14.3 Immutep Limited Dendritic Cell Cancer Vaccine Major Product Offerings
7.14.4 Immutep Limited Dendritic Cell Cancer Vaccine Sales and Revenue in Global (2017-2022)
7.14.5 Immutep Limited Key News
7.15 Dendreon Corporation
7.15.1 Dendreon Corporation Corporate Summary
7.15.2 Dendreon Corporation Business Overview
7.15.3 Dendreon Corporation Dendritic Cell Cancer Vaccine Major Product Offerings
7.15.4 Dendreon Corporation Dendritic Cell Cancer Vaccine Sales and Revenue in Global (2017-2022)
7.15.5 Dendreon Corporation Key News
7.16 Oncobiomed
7.16.1 Oncobiomed Corporate Summary
7.16.2 Oncobiomed Business Overview
7.16.3 Oncobiomed Dendritic Cell Cancer Vaccine Major Product Offerings
7.16.4 Oncobiomed Dendritic Cell Cancer Vaccine Sales and Revenue in Global (2017-2022)
7.16.5 Oncobiomed Key News
8 Global Dendritic Cell Cancer Vaccine Production Capacity, Analysis
8.1 Global Dendritic Cell Cancer Vaccine Production Capacity, 2017-2028
8.2 Dendritic Cell Cancer Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Dendritic Cell Cancer Vaccine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Dendritic Cell Cancer Vaccine Supply Chain Analysis
10.1 Dendritic Cell Cancer Vaccine Industry Value Chain
10.2 Dendritic Cell Cancer Vaccine Upstream Market
10.3 Dendritic Cell Cancer Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Dendritic Cell Cancer Vaccine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Dendritic Cell Cancer Vaccine in Global Market
Table 2. Top Dendritic Cell Cancer Vaccine Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Dendritic Cell Cancer Vaccine Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Dendritic Cell Cancer Vaccine Revenue Share by Companies, 2017-2022
Table 5. Global Dendritic Cell Cancer Vaccine Sales by Companies, (K Doses), 2017-2022
Table 6. Global Dendritic Cell Cancer Vaccine Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Dendritic Cell Cancer Vaccine Price (2017-2022) & (USD/Dose)
Table 8. Global Manufacturers Dendritic Cell Cancer Vaccine Product Type
Table 9. List of Global Tier 1 Dendritic Cell Cancer Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Dendritic Cell Cancer Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Dendritic Cell Cancer Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Dendritic Cell Cancer Vaccine Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Dendritic Cell Cancer Vaccine Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Dendritic Cell Cancer Vaccine Sales (K Doses), 2017-2022
Table 15. By Type - Global Dendritic Cell Cancer Vaccine Sales (K Doses), 2023-2028
Table 16. By Application ? Global Dendritic Cell Cancer Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Dendritic Cell Cancer Vaccine Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Dendritic Cell Cancer Vaccine Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Dendritic Cell Cancer Vaccine Sales (K Doses), 2017-2022
Table 20. By Application - Global Dendritic Cell Cancer Vaccine Sales (K Doses), 2023-2028
Table 21. By Region ? Global Dendritic Cell Cancer Vaccine Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Dendritic Cell Cancer Vaccine Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Dendritic Cell Cancer Vaccine Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Dendritic Cell Cancer Vaccine Sales (K Doses), 2017-2022
Table 25. By Region - Global Dendritic Cell Cancer Vaccine Sales (K Doses), 2023-2028
Table 26. By Country - North America Dendritic Cell Cancer Vaccine Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Dendritic Cell Cancer Vaccine Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Dendritic Cell Cancer Vaccine Sales, (K Doses), 2017-2022
Table 29. By Country - North America Dendritic Cell Cancer Vaccine Sales, (K Doses), 2023-2028
Table 30. By Country - Europe Dendritic Cell Cancer Vaccine Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Dendritic Cell Cancer Vaccine Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Dendritic Cell Cancer Vaccine Sales, (K Doses), 2017-2022
Table 33. By Country - Europe Dendritic Cell Cancer Vaccine Sales, (K Doses), 2023-2028
Table 34. By Region - Asia Dendritic Cell Cancer Vaccine Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Dendritic Cell Cancer Vaccine Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Dendritic Cell Cancer Vaccine Sales, (K Doses), 2017-2022
Table 37. By Region - Asia Dendritic Cell Cancer Vaccine Sales, (K Doses), 2023-2028
Table 38. By Country - South America Dendritic Cell Cancer Vaccine Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Dendritic Cell Cancer Vaccine Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Dendritic Cell Cancer Vaccine Sales, (K Doses), 2017-2022
Table 41. By Country - South America Dendritic Cell Cancer Vaccine Sales, (K Doses), 2023-2028
Table 42. By Country - Middle East & Africa Dendritic Cell Cancer Vaccine Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Dendritic Cell Cancer Vaccine Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Dendritic Cell Cancer Vaccine Sales, (K Doses), 2017-2022
Table 45. By Country - Middle East & Africa Dendritic Cell Cancer Vaccine Sales, (K Doses), 2023-2028
Table 46. Activarti Corporate Summary
Table 47. Activarti Dendritic Cell Cancer Vaccine Product Offerings
Table 48. Activarti Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 49. Argos Therapeutics Corporate Summary
Table 50. Argos Therapeutics Dendritic Cell Cancer Vaccine Product Offerings
Table 51. Argos Therapeutics Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 52. SOTIO (Acquired by PPF Group) Corporate Summary
Table 53. SOTIO (Acquired by PPF Group) Dendritic Cell Cancer Vaccine Product Offerings
Table 54. SOTIO (Acquired by PPF Group) Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 55. Bellicum Pharmaceuticals Corporate Summary
Table 56. Bellicum Pharmaceuticals Dendritic Cell Cancer Vaccine Product Offerings
Table 57. Bellicum Pharmaceuticals Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 58. JW CreaGene Corporate Summary
Table 59. JW CreaGene Dendritic Cell Cancer Vaccine Product Offerings
Table 60. JW CreaGene Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 61. DanDrit Corporate Summary
Table 62. DanDrit Dendritic Cell Cancer Vaccine Product Offerings
Table 63. DanDrit Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 64. DCPrime Corporate Summary
Table 65. DCPrime Dendritic Cell Cancer Vaccine Product Offerings
Table 66. DCPrime Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 67. Elios Therapeutics Corporate Summary
Table 68. Elios Therapeutics Dendritic Cell Cancer Vaccine Product Offerings
Table 69. Elios Therapeutics Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 70. ImmunoCellular Therapeutics Corporate Summary
Table 71. ImmunoCellular Therapeutics Dendritic Cell Cancer Vaccine Product Offerings
Table 72. ImmunoCellular Therapeutics Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 73. Kiromic Corporate Summary
Table 74. Kiromic Dendritic Cell Cancer Vaccine Product Offerings
Table 75. Kiromic Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 76. Medigene Corporate Summary
Table 77. Medigene Dendritic Cell Cancer Vaccine Product Offerings
Table 78. Medigene Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 79. Merck Corporate Summary
Table 80. Merck Dendritic Cell Cancer Vaccine Product Offerings
Table 81. Merck Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 82. Northwest Biotherapeutics Corporate Summary
Table 83. Northwest Biotherapeutics Dendritic Cell Cancer Vaccine Product Offerings
Table 84. Northwest Biotherapeutics Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 85. Immutep Limited Corporate Summary
Table 86. Immutep Limited Dendritic Cell Cancer Vaccine Product Offerings
Table 87. Immutep Limited Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 88. Dendreon Corporation Corporate Summary
Table 89. Dendreon Corporation Dendritic Cell Cancer Vaccine Product Offerings
Table 90. Dendreon Corporation Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 91. Oncobiomed Corporate Summary
Table 92. Oncobiomed Dendritic Cell Cancer Vaccine Product Offerings
Table 93. Oncobiomed Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 94. Dendritic Cell Cancer Vaccine Production Capacity (K Doses) of Key Manufacturers in Global Market, 2020-2022 (K Doses)
Table 95. Global Dendritic Cell Cancer Vaccine Capacity Market Share of Key Manufacturers, 2020-2022
Table 96. Global Dendritic Cell Cancer Vaccine Production by Region, 2017-2022 (K Doses)
Table 97. Global Dendritic Cell Cancer Vaccine Production by Region, 2023-2028 (K Doses)
Table 98. Dendritic Cell Cancer Vaccine Market Opportunities & Trends in Global Market
Table 99. Dendritic Cell Cancer Vaccine Market Drivers in Global Market
Table 100. Dendritic Cell Cancer Vaccine Market Restraints in Global Market
Table 101. Dendritic Cell Cancer Vaccine Raw Materials
Table 102. Dendritic Cell Cancer Vaccine Raw Materials Suppliers in Global Market
Table 103. Typical Dendritic Cell Cancer Vaccine Downstream
Table 104. Dendritic Cell Cancer Vaccine Downstream Clients in Global Market
Table 105. Dendritic Cell Cancer Vaccine Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Dendritic Cell Cancer Vaccine Segment by Type
Figure 2. Dendritic Cell Cancer Vaccine Segment by Application
Figure 3. Global Dendritic Cell Cancer Vaccine Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Dendritic Cell Cancer Vaccine Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Dendritic Cell Cancer Vaccine Revenue, 2017-2028 (US$, Mn)
Figure 7. Dendritic Cell Cancer Vaccine Sales in Global Market: 2017-2028 (K Doses)
Figure 8. The Top 3 and 5 Players Market Share by Dendritic Cell Cancer Vaccine Revenue in 2021
Figure 9. By Type - Global Dendritic Cell Cancer Vaccine Sales Market Share, 2017-2028
Figure 10. By Type - Global Dendritic Cell Cancer Vaccine Revenue Market Share, 2017-2028
Figure 11. By Type - Global Dendritic Cell Cancer Vaccine Price (USD/Dose), 2017-2028
Figure 12. By Application - Global Dendritic Cell Cancer Vaccine Sales Market Share, 2017-2028
Figure 13. By Application - Global Dendritic Cell Cancer Vaccine Revenue Market Share, 2017-2028
Figure 14. By Application - Global Dendritic Cell Cancer Vaccine Price (USD/Dose), 2017-2028
Figure 15. By Region - Global Dendritic Cell Cancer Vaccine Sales Market Share, 2017-2028
Figure 16. By Region - Global Dendritic Cell Cancer Vaccine Revenue Market Share, 2017-2028
Figure 17. By Country - North America Dendritic Cell Cancer Vaccine Revenue Market Share, 2017-2028
Figure 18. By Country - North America Dendritic Cell Cancer Vaccine Sales Market Share, 2017-2028
Figure 19. US Dendritic Cell Cancer Vaccine Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Dendritic Cell Cancer Vaccine Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Dendritic Cell Cancer Vaccine Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Dendritic Cell Cancer Vaccine Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Dendritic Cell Cancer Vaccine Sales Market Share, 2017-2028
Figure 24. Germany Dendritic Cell Cancer Vaccine Revenue, (US$, Mn), 2017-2028
Figure 25. France Dendritic Cell Cancer Vaccine Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Dendritic Cell Cancer Vaccine Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Dendritic Cell Cancer Vaccine Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Dendritic Cell Cancer Vaccine Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Dendritic Cell Cancer Vaccine Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Dendritic Cell Cancer Vaccine Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Dendritic Cell Cancer Vaccine Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Dendritic Cell Cancer Vaccine Sales Market Share, 2017-2028
Figure 33. China Dendritic Cell Cancer Vaccine Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Dendritic Cell Cancer Vaccine Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Dendritic Cell Cancer Vaccine Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Dendritic Cell Cancer Vaccine Revenue, (US$, Mn), 2017-2028
Figure 37. India Dendritic Cell Cancer Vaccine Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Dendritic Cell Cancer Vaccine Revenue Market Share, 2017-2028
Figure 39. By Country - South America Dendritic Cell Cancer Vaccine Sales Market Share, 2017-2028
Figure 40. Brazil Dendritic Cell Cancer Vaccine Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Dendritic Cell Cancer Vaccine Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Dendritic Cell Cancer Vaccine Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Dendritic Cell Cancer Vaccine Sales Market Share, 2017-2028
Figure 44. Turkey Dendritic Cell Cancer Vaccine Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Dendritic Cell Cancer Vaccine Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Dendritic Cell Cancer Vaccine Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Dendritic Cell Cancer Vaccine Revenue, (US$, Mn), 2017-2028
Figure 48. Global Dendritic Cell Cancer Vaccine Production Capacity (K Doses), 2017-2028
Figure 49. The Percentage of Production Dendritic Cell Cancer Vaccine by Region, 2021 VS 2028
Figure 50. Dendritic Cell Cancer Vaccine Industry Value Chain
Figure 51. Marketing Channels
